Sondra Berger to Thymidylate Synthase
This is a "connection" page, showing publications Sondra Berger has written about Thymidylate Synthase.
Connection Strength
2.152
-
Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach. PLoS One. 2018; 13(3):e0193810.
Score: 0.610
-
Evolution of metamorphism in thymidylate synthases within the primate lineages. J Mol Evol. 2011 Mar; 72(3):306-14.
Score: 0.373
-
Human thymidylate synthase with loop 181-197 stabilized in an inactive conformation: ligand interactions, phosphorylation, and inhibition profiles. Protein Sci. 2011 Jan; 20(1):87-94.
Score: 0.370
-
Thymidylate synthase as a chemotherapeutic drug target: where are we after fifty years? Cancer Biol Ther. 2006 Sep; 5(9):1238-41.
Score: 0.275
-
Effects of ligand binding and conformational switching on intracellular stability of human thymidylate synthase. Biochim Biophys Acta. 2004 Jan 14; 1696(1):15-22.
Score: 0.229
-
Replacement of Val3 in human thymidylate synthase affects its kinetic properties and intracellular stability . Biochemistry. 2010 Mar 23; 49(11):2475-82.
Score: 0.088
-
Variants of human thymidylate synthase with loop 181-197 stabilized in the inactive conformation. Protein Sci. 2009 Aug; 18(8):1628-36.
Score: 0.084
-
Determination of apoptosis, uracil incorporation, DNA strand breaks, and sister chromatid exchanges under conditions of thymidylate deprivation in a model of BER deficiency. Biochem Pharmacol. 2005 Nov 15; 70(10):1458-68.
Score: 0.064
-
Involvement of base excision repair in response to therapy targeted at thymidylate synthase. Mol Cancer Ther. 2004 Jun; 3(6):747-53.
Score: 0.059